{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:42:07Z","timestamp":1790534527551,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yebeh.2020.107187","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T12:27:25Z","timestamp":1593260845000},"page":"107187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence"],"prefix":"10.1016","volume":"111","author":[{"given":"Gia","family":"Melikishvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Gataullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107187_bb0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000447526","article-title":"Phenotypic variability from benign infantile epilepsy to Ohtahara syndrome associated with a novel mutation in SCN2A","volume":"7","author":"Syrbe","year":"2016","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.yebeh.2020.107187_bb0010","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/brain\/awx054","article-title":"Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders","volume":"140","author":"Wolff","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2020.107187_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.braindev.2016.10.015","article-title":"Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy","volume":"39","author":"Dilena","year":"2017","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2020.107187_bb0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1684\/epd.2018.1001","article-title":"Lacosamide for SCN2A-related intractable neonatal and infantile seizures","volume":"20","author":"Flor-Hirsch","year":"2018","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2020.107187_bb0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1528-1157.1994.tb01782.x","article-title":"EEG changes and seizure exacerbation in young children treated with carhamazepine","volume":"35","author":"Talwar","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107187_bb0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0387-7604(87)80110-9","article-title":"The early infantile epileptic encephalopathy with suppression-burst: developmental aspects","volume":"9","author":"Ohtahara","year":"1987","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2020.107187_bb0035","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/WNL.0b013e3182a43e57","article-title":"Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome","volume":"81","author":"Nakamura","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107187_bb0040","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.0000000000001926","article-title":"SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures","volume":"85","author":"Howell","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107187_bb0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1528-1157.1995.tb00961.x","article-title":"Migrating partial seizures in infancy: a malignant disorder with developmental arrest","volume":"36","author":"Coppola","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107187_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1469-8749.1987.tb02512.x","article-title":"Early infantile epileptic encephalopathy with suppression burst: Ohtahara syndrome","volume":"29","author":"Clarke","year":"1987","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107187_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0387-7604(01)00392-8","article-title":"Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases","volume":"24","author":"Yamatogi","year":"2002","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2020.107187_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1684\/epd.2014.0641","article-title":"Confirming an expanded spectrum of SCN2A mutations: a case series","volume":"16","author":"Matalon","year":"2014","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2020.107187_bb0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-pharmtox-011112-140232","article-title":"Sodium channels, inherited epilepsy, and antiepileptic drugs","volume":"54","author":"Catterall","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.yebeh.2020.107187_bb0085","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1002\/j.1460-2075.1989.tb08534.x","article-title":"Differential regulation of three sodium channel messengers RNAs in the rat central nervous system during development","volume":"8","author":"Beckh","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.yebeh.2020.107187_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-7091-6721-2_19","article-title":"RNA microarray analysis of channels and transporters in normal and fetal Down syndrome (trisomy 21) brain","volume":"67","author":"Lubec","year":"2003","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.yebeh.2020.107187_bb0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0896-6273(02)01053-X","article-title":"Paracrine intercellular communication by a Ca2+- and SNARE-independent release of GABA and glutamate prior to synapse formation","volume":"36","author":"Demarque","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2020.107187_bb0080","first-page":"71","article-title":"Severe myoclonic epilepsy in infancy: Dravet syndrome","volume":"95","author":"Dravet","year":"2005","journal-title":"Adv Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:34:03Z","timestamp":1761503643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020303668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":17,"alternative-id":["S1525505020303668"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107187","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107187"}}